IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
PRA Health Sciences, Inc. is a global contract research organization (CRO) that provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. It organizes its business into three segments: the Product Registration Services segment, which designs, manages, and implements study protocols for Phase II through Phase III clinical trials; the Strategic Solutions segment, which provides embedded solutions and functional outsourcing services; and the Early Development Services segment, which consists of Phase I through Phase IIa clinical trials and bioanalytical laboratory services. It also offers back-office services, including payment processing, imaging, laboratory, and patient recruitment services. It maintains its facilities worldwide. The firm was incorporated in Delaware on June 21, 2013. Its headquarters are located in Raleigh, North Carolina.
IBISWorld's SupplierIQ profile covering Pra Health Sciences, Inc. includes financial statements, products & service markets, competitive position and key financial health ratios.
This SupplierIQ profile on Pra Health Sciences, Inc. covers the company’s financial statements, products & service markets, competitive position and key financial health ratios. Pra Health Sciences, Inc., trading as Pra Health Sciences, is a public company with 18.1k employees.
Pra Health Sciences, Inc. primarily operates in Medical Laboratories, as well as in Scientific Research & Development in the US.
The Product & Service Markets chapter provides a breakdown of Pra Health Sciences, Inc.’s key product and service segments, organized by standardized industry classifications like NAICS. It includes their market share in each of these markets with market share trends and insights.
The Competitive Position chapter covers Pra Health Sciences, Inc.’s performance relative to competitors in each of the products and service markets the company operates in. This includes a detailed competitor matrix comparing the market share, return on assets, return on equity, pricing power and competitive outlook. There are qualitative insights and a detailed SWOT analysis included for each product and service market.
The Income Statement chapter includes datasets covering Pra Health Sciences, Inc.’s historical financial performance. Line items include revenue, cost of sales, gross margins, general and administrative costs, research and development costs, depreciation, interest and taxes. This is available in current and historical datasets.
The Balance Sheet chapter includes datasets covering Pra Health Sciences, Inc.’s historical financial health. Current asset and non-current asset accounts include line items like cash, receivables, inventories, property, plant and equipment, investments, goodwill. Current liabilities and non-current liabilities accounts include line items like accounts payable, debts, provisions and lease liabilities. The equity accounts include line items like paid-in capital, retained earnings, employee stock option plans and treasury stock. This is available in current and historical datasets.
The Cash Flows chapter includes detailed line item accounts covering Pra Health Sciences, Inc.’s operating cash flow activities, financing cash flow activities and investing cash flow activities. This is available in current and historical datasets.
The Ratios chapter covers key financial metrics like the operating margin, gross margin, return on equity, return on assets, current ratio, quick ratio, EBIT margins, EBITDA margins, debt ratio, equity ratio and debt to equity ratios. This is available in current and historical datasets.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
According to the 2026 IBISWorld ProcurementIQ report, Pra Health Sciences, Inc. generated $3.2bn in revenue.
The 2026 ProcurementIQ report benchmarks Pra Health Sciences, Inc. against its top competitors across execution score, operational capabilities, pricing power, and market share.
Pra Health Sciences, Inc.’s EBITDA margin is reported across a 7-year period in the 2026 IBISWorld ProcurementIQ report. The report includes a full income statement breakdown.
The 2026 report identifies all NAICS-coded product and service markets Pra Health Sciences, Inc. participates in, including market share, concentration, profitability trends, and average vendor risk ratings.
The 2026 ProcurementIQ report lists Pra Health Sciences, Inc.’s employee count and benchmarks workforce size against key competitors to assess relative operational capacity.